The identified RYR1 SNPs could serve as genetic markers for subgroups of HF patients who might benefit from tailored treatment approaches, guiding clinicians in selecting the most appropriate therapeutic strategies for individual patients. The gene discussed is RYR1; the disease is hydrops fetalis.